These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31398149)

  • 1. Predictors of inappropriate shocks from implantable cardioverter-defibrillators.
    Jagielski D; Zyśko D; Nadolny K; Wizowska J; Biel B; Banasiak W; Ponikowski P
    Wiad Lek; 2019; 72(7):1243-1246. PubMed ID: 31398149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathy.
    Woo A; Monakier D; Harris L; Hill A; Shah P; Wigle ED; Rakowski H; Rozenblyum E; Cameron DA
    Heart; 2007 Sep; 93(9):1044-5. PubMed ID: 17699173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
    Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term incidence of inappropriate shocks in patients with implantable cardioverter defibrillators in clinical practice-an underestimated complication?
    Hofer D; Steffel J; Hürlimann D; Haegeli L; Lüscher TF; Duru F; Eriksson U; Krasniqi N
    J Interv Card Electrophysiol; 2017 Dec; 50(3):219-226. PubMed ID: 29177981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of subcutaneous implantable cardioverter-defibrillators and determinants of inappropriate shock delivery.
    Mesquita J; Cavaco D; Ferreira A; Lopes N; Santos PG; Carvalho MS; Haas A; Costa F; Carmo P; Morgado F; Adragão P; Mendes M
    Int J Cardiol; 2017 Apr; 232():176-180. PubMed ID: 28082086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter-defibrillators in patients with long QT syndrome: a multicentre study.
    Zienciuk-Krajka A; Sterliński M; Filipecki A; Owczuk R; Bednarek J; Kempa M; Sielski S; Dziduszko M; Mitkowski P; Kaźmierczak J; Kuśnierz J; Michałkiewicz D; Stec SM; Gułaj M; Majcherek R; Lubiński A; Raczak G
    Kardiol Pol; 2018; 76(12):1687-1696. PubMed ID: 30251242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of implantable cardioverter-defibrillators in children: Indications and outcomes.
    Kwiatkowska J; Budrejko S; Wasicionek M; Meyer-Szary FJ; Lubinski A; Kempa M
    Adv Clin Exp Med; 2020 Jan; 29(1):123-133. PubMed ID: 31895976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
    Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
    Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors and Proarrhythmic Consequences of Inappropriate Implantable Cardioverter-Defibrillator Therapy.
    Tenma T; Yokoshiki H; Mizukami K; Mitsuyama H; Watanabe M; Sasaki R; Maeno M; Matsui Y; Tsutsui H
    Circ J; 2015; 79(9):1920-7. PubMed ID: 26104029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks.
    van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results.
    Auricchio A; Schloss EJ; Kurita T; Meijer A; Gerritse B; Zweibel S; AlSmadi FM; Leng CT; Sterns LD;
    Heart Rhythm; 2015 May; 12(5):926-36. PubMed ID: 25637563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
    J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of implantable cardioverter-defibrillator implantation in secondary prevention of sudden cardiac death.
    Boulé S; Sémichon M; Guédon-Moreau L; Drumez É; Kouakam C; Marquié C; Brigadeau F; Kacet S; Potelle C; Escande W; Souissi Z; Lacroix D; Duhamel A; Klug D
    Arch Cardiovasc Dis; 2016 Oct; 109(10):517-526. PubMed ID: 27342808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
    Syska P; Przybylski A; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Gepner K; Pytkowski M; Kowalik I; Maczyńska-Mazuruk R; Ruzyłło W; Szwed H
    J Cardiovasc Electrophysiol; 2010 Aug; 21(8):883-9. PubMed ID: 20132378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired left atrial function predicts inappropriate shocks in primary prevention implantable cardioverter-defibrillator candidates.
    Tao S; Ashikaga H; Ciuffo LA; Yoneyama K; Lima JAC; Frank TF; Weiss RG; Tomaselli GF; Wu KC
    J Cardiovasc Electrophysiol; 2017 Jul; 28(7):796-805. PubMed ID: 28429529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: A systematic review and meta-analysis of inappropriate shocks and complications.
    Olde Nordkamp LR; Postema PG; Knops RE; van Dijk N; Limpens J; Wilde AA; de Groot JR
    Heart Rhythm; 2016 Feb; 13(2):443-54. PubMed ID: 26385533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.
    Bettin M; Larbig R; Rath B; Fischer A; Frommeyer G; Reinke F; Köbe J; Eckardt L
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1499-1506. PubMed ID: 29759830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.